Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Publication of SPiReL data and class action
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(43)
•••
Comment by Breakthorough1on Jul 27, 2023 1:15pm
98 Views
Post# 35559896

RE:RE:Publication of SPiReL data and class action

RE:RE:Publication of SPiReL data and class actionIs this is the rumor, we should collect all the misleading statements and initiate a class action. They are any:

- Announcements related to COVID Vaccine resukts which never came.

- Announcements related to VITALIZE results giving a date always delayed.

- Announcements about financind, like that of Andrew Hall in an interview with Thom Calandra in January 2022, where it was stated that Merck was going to finance trials in Bladder and MSI-H. cancers.

And so on...

Has anyone contacted a lawyer?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities